Stanton Glantz

Last updated

Stanton Glantz
Born1946 (age 7778)
Alma mater University of Cincinnati, Stanford University
Known forResearch into health effects of tobacco and regulation of tobacco products
SpouseMarsha Glantz
Children Aaron and Frieda Glantz
AwardsElected to the Institute of Medicine in 2005
Scientific career
Fields Cardiology, public health
Institutions University of California, San Francisco
Thesis A mathematical approach to cardiac muscle physiology  (1973)

Stanton Arnold Glantz (born 1946) is an American professor, author, and tobacco control activist. Glantz is a faculty member at the University of California, San Francisco (UCSF) School of Medicine, where he is a Professor of Medicine (retired) in the Division of Cardiology, the American Legacy Foundation Distinguished Professor of Tobacco Control, and former director of the Center for Tobacco Control Research and Education. [1] Glantz's research focused on the health effects of tobacco smoking.

Contents

Described as the "Ralph Nader of the anti-tobacco movement," [2] [3] Glantz is an activist for nonsmokers' rights and an advocate of public health policies to reduce smoking. He is the author of four books, including The Cigarette Papers [4] and Primer of Biostatistics. [5] Glantz is also a member of the UCSF Cardiovascular Research Institute and Institute for Health Policy Studies, [6] and co-leader of the UCSF Comprehensive Cancer Center Tobacco Program. He was elected to the Institute of Medicine in 2005.

In 2017, Glantz was sued by a former postdoctoral researcher for alleged sexual harassment and retaliation. While UCSF internally found that Glantz had "more likely than not" engaged in harassment and had violated the faculty code of conduct, [7] Glantz and UCSF publicly denied the allegations and settled the lawsuit for $150,000. [8] In 2018, a second former employee sued Glantz for harassment; Glantz and UCSF denied these allegations as well. [9]

Life and career

Glantz was the first of two children born in Cleveland, Ohio to Louis Glantz, an insurance salesman, and Frieda, a real estate broker. As a youth, Glantz took a great interest in the Soviet Union's Sputnik 1 satellite. [10] He was a member of the Boy Scouts of America, where he achieved the top rank of Eagle Scout, and earned a Bronze Palm for further achievements. [11]

Glantz obtained a B.Sc. in aerospace engineering from the University of Cincinnati in 1969, an M.Sc. in applied mechanics from Stanford University in 1970, and in 1973, a Ph.D. from Stanford in applied mechanics (concentrating on the mechanics of the human heart) and engineering-economic systems (EES is a Stanford department created in the late 1960s, integrating computers and engineering in "methods of systems and economic analysis to engineering problems involving policy and decision making, both in government and industry"). [12] Concurrently with his studies, he worked at NASA's Manned Spacecraft Center, first as a student trainee, then as an aerospace engineer. In 1973, Glantz carried out postdoctoral research on the mathematical modeling of heart tissue at Stanford, and then at the UCSF, where he has worked since 1977. [11] [13]

He served for 10 years as an Associate Editor of the Journal of the American College of Cardiology and is a member of the California State Scientific Review Panel on Toxic Air Contaminants of the California Air Resources Board. He is married to Marsha, a home-care nurse; and is the father of journalist Aaron Glantz and daughter Frieda Glantz. [10] In 2005, he was elected to the prestigious Institute of Medicine. [14] Known for being blunt and abrasive, Glantz embraces his public image and controversial positions on smoking, on occasion wearing a "Here Comes Trouble" T-shirt. [2] [15]

Research

Glantz conducts research on a wide range of issues including the effects of secondhand smoke on the heart by studying reductions in heart attacks observed when smoke-free policies are enacted, and how the tobacco industry fights tobacco control programs. His research on the effects of secondhand smoke on blood and blood vessels concludes that, in terms of heart disease, the effects of secondhand smoke are nearly as large as those of smoking. [16] One such study demonstrated a large and rapid reduction in the number of people admitted to the hospital with heart attacks in Helena, Montana, [17] after that community made all workplaces and public places smokefree.

Glantz is author or coauthor of numerous publications related to secondhand smoke and tobacco control, as well as many papers on cardiovascular function and biostatistics. He published the first study linking e-cigarettes to heart attacks in people. [18] He has written several books, including the widely used Primer of Biostatistics (which has been translated into Japanese, French, Russian, German, Italian, Japanese and Spanish), and Primer of Applied Regression and Analysis of Variance. In total, he is the author of 4 books and over 400 scientific papers, including the first major review (published in Circulation ) which identified secondhand smoke as a cause of heart disease and the landmark 1995 Journal of the American Medical Association summary of the Brown & Williamson documents, which showed that the tobacco industry knew nicotine was addictive and that smoking caused cancer 30 years ago. [19] This publication was followed up with his book, The Cigarette Papers, [4] which has played a key role in the ongoing litigation surrounding the tobacco industry. His book Tobacco Wars: Inside the California Battles [20] chronicles the last quarter century of activism against the tobacco industry in California.

Working with the UCSF Library, Glantz helped in making over 90 million pages of previously secret tobacco industry documents available via the internet on the UCSF Truth Tobacco Industry Documents, formerly known as the Legacy Tobacco Documents Library. [21] In February 2013, a paper co-authored by Glantz was published in the journal Tobacco Control . Entitled "‘To quarterback behind the scenes, third-party efforts’: the tobacco industry and the Tea Party", the paper detailed how the Tea Party political movement was funded and organized by organizations which were created by tobacco companies. [22]

In March 2014 Glantz released a study concluding that "e-cigarette use is aggravating rather than ameliorating the tobacco epidemic among youths." [23] Thomas J. Glynn, a researcher at the American Cancer Society, responded that "The data in this study do not allow many of the broad conclusions that it draws" [24] In 2018, the National Academies of Science, Engineering and Medicine reviewed all the available evidence on e-cigarettes and youth and concluded that “there is substantial evidence that e-cigarette use increases risk of ever using combustible cigarettes among youth and young adults." [25]

In March 2024, Glantz and colleagues published "Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes" in NEJM Evidence reporting the associations between e-cigarette use and disease. Based on 107 peer reviewed studies of e-cigarette use in the real world, they concluded that, “Direct epidemiological evidence based on actual use of e-cigarettes in the general population suggests that, at least for cardiovascular disease, stroke, and metabolic dysfunction, the odds of disease between current e-cigarette and cigarette use were similar. For asthma, COPD, and oral disease, although lower than with cigarettes, the odds of disease were still substantial.” [26] The paper also concluded that dual use (using e-cigarettes and cigarettes at the same time) is riskier than smoking alone for all outcomes. The paper has been criticized by an e-cigarette advocate. [27] Glantz responded that all these potential criticisms were addressed in the paper or its technical appendix. [28]

Activism

Glantz has been a leading researcher and activist in the nonsmokers' rights movement since 1978, when he helped lead an unsuccessful state initiative campaign to enact a nonsmokers' rights law by popular vote. In 1983, he helped successfully defend the San Francisco Workplace Smoking Ordinance against a tobacco industry-supported attempt to repeal it by referendum. [29] The San Francisco victory represented the first electoral defeat of such a tobacco industry sponsored referendum, and is now viewed as a major turning point in the battle for nonsmokers' rights. [13] He is one of the founders of Americans for Nonsmokers' Rights.

In 1982 he was part of a group of health activists who resurrected the last remaining copy of the film Death in the West , previously suppressed by Philip Morris, [30] [31] and developed an accompanying mini-course for fifth to tenth graders that has been used by over one million students. [2] [13] [32] He helped write and produce the films Secondhand Smoke, which concerns the health effects of involuntary smoking, and 120,000 Lives, which presents evidence that smoking in the movies recruits adolescent smokers and proposes solutions for reducing this effect. [13] He also wrote Tobacco: Biology and Politics [33] for high school students and The Uninvited Guest, a story about secondhand smoke, for second graders.

In May, 1994, Glantz received at his UCSF office two boxes containing 4,000 documents leaked from Brown & Williamson, the third largest US cigarette manufacturer at the time. The material provided the first definitive proof that the tobacco industry had known for 30 years that nicotine was addictive and caused cancer, and had hidden that knowledge from the public. The documents became a landmark in tobacco litigation, medical scholarship, government policy, and corporate control of information. [34] [35] With four co-authors, Glantz analyzed the documents and, with extensive excerpts, published the findings as The Cigarette Papers.

Glantz appears in several investigative documentaries: Cigarette Wars (2011), a CNBC examination of how the tobacco industry in America "continues to thrive"; [36] and Merchants of Doubt (2014), based on the non-fiction book, Merchants of Doubt , in which the leaked Brown & Williamson tobacco documents play a key role in illustrating tactics created by tobacco companies and copied by others. [37]

Glantz was also an opponent [38] of the Tobacco Master Settlement Agreement (MSA), the "global settlement" of tobacco litigation proposed in 1996, in which the tobacco industry was to be granted de facto immunity from further litigation in exchange for payments to the states and acceptance of regulation by the U.S. Food and Drug Administration. [39] The tobacco industry turned against and defeated this compromise, and defeated legislation introduced in Congress by Senator John McCain (R-AZ), after some public health advocates succeeded in getting the immunity provisions removed. Many of the provisions of the "global settlement"—but not the immunity or FDA provisions—were implemented by the (MSA) between the attorneys general of 46 states and the large tobacco companies. Glantz' analysis of the two agreements concluded that the MSA included most of the desirable provisions of the global settlement without the immunity provisions. In particular, the immunity provisions in the global settlement would have prevented the massive (and successful) federal Racketeer Influenced and Corrupt Organizations Act (RICO) lawsuit that the US Department of Justice won against the tobacco industry in 2007. He is now running a website, SmokeFreeMedia, which is working to end depictions of tobacco use in movies.

Oral history published by University of California

In July, 2023, the Oral History Center at the University of California Bancroft Library published an oral history of Glantz' career. The history follows Glantz from elementary school through college and graduate school, including work to develop the emergency protocols for the Apollo 5 mission while still an undergraduate, and research on the relationship between the Department of Defense funding and university research while at Stanford. Guided by Paul Burnett, an historian of science and director of the Oral History Center, the history discusses how Glantz moved from rocket science to cardiovascular research and public health and talks about the practicalities of working at the interface between science and public policy. Also discussed is Glantz' administrative service to UCSF and the larger University of California system, including advocating for fair and equitable treatment of graduate and post-doctoral students, adjunct and clinical faculty, and research into the feasibility of restoring free high-quality higher education in California.


Harassment allegations

On December 6, 2017, Dr. Eunice Neeley, a former postdoctoral researcher working with Dr. Glantz at UCSF, filed a complaint of sexual harassment against him in San Francisco Superior Court, alleging that Glantz subjected her to misogynistic, racially and sexually insensitive behavior from 2015 to 2017. [40] [41] Dr. Neeley also alleged that when she complained about the harassment to the University, Dr. Glantz retaliated by removing her name from a research paper she had co-authored. [42] The UCSF Associate Vice Chancellor and Research Integrity Officer, Chairman of the Department of Medicine, and Director of the Cardiovascular Research Institute informed the intended journal, American Association for Cancer Research, by letter that "the reason that Dr. Glantz did not include Dr. Neely as an author when he initially submitted the manuscript on May 26, 2017 was that, despite repeated requests, Dr. Neeley had refused to grant Dr. Glantz permission to include her as an author on the paper." [43] Confidential internal UCSF investigations concluded that Glantz had "more likely than not" harassed the former researcher, and that his conduct constituted "hostile work environment sexual harassment" which violated the Faculty Code of Conduct. [7] [8] In September 2018, the Regents of the University of California and Dr. Glantz executed a settlement agreement resolving Dr. Neeley’s lawsuit against the Regents and Dr. Glantz personally. [44] This settlement agreement, signed by all parties, stated that the Regents and Dr. Glantz denied Dr. Neeley’s allegations.

In 2018, a second former employee filed a sexual-harassment lawsuit against Glantz; the University of California and Glantz denied these allegations as well. [9]

Related Research Articles

<span class="mw-page-title-main">Cigarette</span> Small roll of tobacco made to be smoked

A cigarette is a narrow cylinder containing a combustible material, typically tobacco, that is rolled into thin paper for smoking. The cigarette is ignited at one end, causing it to smolder; the resulting smoke is orally inhaled via the opposite end. Cigarette smoking is the most common method of tobacco consumption. The term cigarette, as commonly used, refers to a tobacco cigarette, but the word is sometimes used to refer to other substances, such as a cannabis cigarette or a herbal cigarette. A cigarette is distinguished from a cigar by its usually smaller size, use of processed leaf, different smoking method, and paper wrapping, which is typically white.

<span class="mw-page-title-main">Tobacco industry</span> Persons and companies that produce tobacco-related products

The tobacco industry comprises those persons and companies who are engaged in the growth, preparation for sale, shipment, advertisement, and distribution of tobacco and tobacco-related products. It is a global industry; tobacco can grow in any warm, moist environment, which means it can be farmed on all continents except Antarctica.

<span class="mw-page-title-main">Smoking ban</span> Law prohibiting tobacco smoking in a given space

Smoking bans, or smoke-free laws, are public policies, including criminal laws and occupational safety and health regulations, that prohibit tobacco smoking in certain spaces. The spaces most commonly affected by smoking bans are indoor workplaces and buildings open to the public such as restaurants, bars, office buildings, schools, retail stores, hospitals, libraries, transport facilities, and government buildings, in addition to public transport vehicles such as aircraft, buses, watercraft, and trains. However, laws may also prohibit smoking in outdoor areas such as parks, beaches, pedestrian plazas, college and hospital campuses, and within a certain distance from the entrance to a building, and in some cases, private vehicles and multi-unit residences.

<span class="mw-page-title-main">Passive smoking</span> Inhalation of tobacco smoke by persons other than the intended active smoker

Passive smoking is the inhalation of tobacco smoke, called passive smoke, secondhand smoke (SHS) or environmental tobacco smoke (ETS), by individuals other than the active smoker. It occurs when tobacco smoke diffuses into the surrounding atmosphere as an aerosol pollutant, which leads to its inhalation by nearby bystanders within the same environment. Exposure to secondhand tobacco smoke causes many of the same health effects caused by active smoking, although to a lower prevalence due to the reduced concentration of smoke that enters the airway.

<span class="mw-page-title-main">Cotinine</span> Alkaloid found in tobacco

Cotinine is an alkaloid found in tobacco and is also the predominant metabolite of nicotine, typically used as a biomarker for exposure to tobacco smoke. Cotinine is currently being studied as a treatment for depression, post-traumatic stress disorder (PTSD), schizophrenia, Alzheimer's disease and Parkinson's disease. Cotinine was developed as an antidepressant as a fumaric acid salt, cotinine fumarate, to be sold under the brand name Scotine, but it was never marketed.

<span class="mw-page-title-main">Marlboro Man</span> Marlboro cigarette icon used in advertising for Marlboro.

The Marlboro Man is a figure that was used in tobacco advertising campaigns for Marlboro cigarettes. In the United States, where the campaign originated, it was used from 1954 to 1999. The Marlboro Man was first conceived by Leo Burnett in 1954. The images initially featured rugged men portrayed in a variety of roles but later primarily featured a rugged cowboy or cowboys in picturesque wild terrain. The ads were originally conceived as a way to popularize filtered cigarettes, which at the time were considered feminine.

<span class="mw-page-title-main">Nicotine marketing</span> Marketing technique

Nicotine marketing is the marketing of nicotine-containing products or use. Traditionally, the tobacco industry markets cigarette smoking, but it is increasingly marketing other products, such as electronic cigarettes and heated tobacco products. Products are marketed through social media, stealth marketing, mass media, and sponsorship. Expenditures on nicotine marketing are in the tens of billions a year; in the US alone, spending was over US$1 million per hour in 2016; in 2003, per-capita marketing spending was $290 per adult smoker, or $45 per inhabitant. Nicotine marketing is increasingly regulated; some forms of nicotine advertising are banned in many countries. The World Health Organization recommends a complete tobacco advertising ban.

<span class="mw-page-title-main">Health effects of tobacco</span> Circumstances, mechanisms, and factors of tobacco consumption on human health

Tobacco products, especially when smoked or used orally, have serious negative effects on human health. Smoking and smokeless tobacco use is the single greatest cause of preventable death globally. As many as half of people who smoke tobacco or use it orally die from complications related to such use. It has been estimated that each year, in total about 6 million people die from tobacco-related causes, with 600,000 of these occurring in non-smokers due to secondhand smoke. It is further estimated to have caused 100 million deaths in the 20th century.

<span class="mw-page-title-main">Smoking in Argentina</span> Overview of smoking in Argentina

Smoking in Argentina accounts for 15% of total tobacco consumption in the Americas. In the 20th century, the government promoted settlement and economic development in the northern subtropical zones, with tobacco playing a central role. A new government agency worked to educate farmers and promote the cultivation, processing, and marketing of tobacco. While tobacco factories were initially concentrated around Buenos Aires, they gradually extended into the northern production regions. By 1960, Argentina accomplished self-sufficiency in tobacco production. By the 1970s, its annual output exceeded 60,000 metric tons, with one-third exported. At the local level cooperatives are active, they sell to one of two multinational companies, Nobleza-Picardo, an affiliate of the British American Tobacco company, and Messalin-Particulares, associated with Philip Morris International. Argentina held the global rank of third place in terms of production, trailing behind Brazil and Mexico.

Operation Berkshire is the name of a program initiated in 1976 by seven of the world's major tobacco companies aimed at promoting "controversy" over smoking and disease.

Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the use of drugs. Tobacco smoking is widely acknowledged as a leading cause of illness and death, and reducing smoking is vital to public health.

<span class="mw-page-title-main">Electronic cigarette</span> Device that vaporizes a liquid nicotine solution for inhalation

An electronic cigarette (e-cigarette) or vape is a device that simulates tobacco smoking. It consists of an atomizer, a power source such as a battery, and a container such as a cartridge or tank. Instead of smoke, the user inhales vapor. As such, using an e-cigarette is often called "vaping". The atomizer is a heating element that vaporizes a liquid solution called e-liquid, which quickly cools into an aerosol of tiny droplets, vapor and air. The vapor mainly comprises propylene glycol and/or glycerin, usually with nicotine and flavoring. Its exact composition varies, and depends on several things including user behavior.

The Tobacco Institute, Inc. was a United States tobacco industry trade group, founded in 1958 by the American tobacco industry. It was dissolved in 1998 as part of the Tobacco Master Settlement Agreement.

Smoking in China is prevalent, as the People's Republic of China is the world's largest consumer and producer of tobacco. As of 2022, there are around 300 million Chinese smokers, and 2.4 trillion cigarettes are sold there every year, 46% of the world total.

Smoking in South Korea has decreased overall for both men and women in the past decades. However, a high prevalence of tobacco use is still observed, especially with the rise of novel tobacco products such as e-cigarettes and heat-not-burn tobacco products. There are socioeconomic inequalities in smoking prevalence according to gender, income, education, and occupational class. Advocates call for measures to reduce the smoking rates and address smoking inequalities using a combination of monitoring and tobacco control policies. These measures include significant price hikes, mandatory warning photos on cigarette packs, advertising bans, financial incentives, medical help for quitting, and complete smoking bans in public places.

<span class="mw-page-title-main">Lisa Bero</span> American scientist

Lisa Anne Bero, born 1958, is an academic who originally trained in pharmacology and went on to a career studying research integrity and how clinical and basic sciences are translated into clinical practice and health policy. Bero is a Professor of Medicine and Public Health and the Chief Scientist of the Center for Bioethics and Humanities at the University of Colorado. Previously, she had been Chair of Medicines Use and Health Outcomes at the University of Sydney. From 1991 until 2014, she was Professor in the Department of Clinical Pharmacy and in the Institute of Health Policy Studies at the University of California, San Francisco (UCSF), and is currently an adjunct professor there. She is also Chair of the World Health Organization (WHO) Essential Medicines Committee, Director of the WHO Collaborating Centre for Pharmaceutical Research and Science Policy, and was Co-Chair of the Cochrane Collaboration from 2013 to 2017. Bero has received multiple awards for her extensive mentoring of high school students to junior faculty.

Geoffrey C. Kabat is an American epidemiologist, cancer researcher, and author. He has been on the faculty of the Albert Einstein College of Medicine and State University of New York, Stony Brook. He was co-author of a discredited BMJ study funded by the tobacco industry, that erroneously said there was no association between secondhand smoke and health problems.

Michael B. Siegel is an American tobacco control researcher and public health researcher. He is a professor of community health sciences at the Boston University School of Public Health.

The Center for Indoor Air Research was a tobacco industry front group established by three American tobacco companies—Philip Morris, R.J. Reynolds, and Lorillard—in Linthicum, Maryland, in 1988. The organization funded research on indoor air pollution, some of which pertained to passive smoking and some of which did not. It also funded research pertaining to causes of lung cancer other than passive smoking, such as diet. The organization disbanded in 1998 as a result of the Tobacco Master Settlement Agreement.

<span class="mw-page-title-main">Tobacco-free college campuses</span>

Tobacco-free college campuses are institutions that have enacted comprehensive policies banning the use of tobacco products across all indoor and outdoor areas of their grounds. These policies stem from the well-documented health risks associated with tobacco, not only for users but also for those exposed to secondhand smoke, as well as the environmental damage caused by tobacco waste. In response to these concerns, colleges and universities have increasingly adopted tobacco-free policies to enhance public health, create a more pleasant campus atmosphere, and mitigate the environmental impact of tobacco use.

References

  1. "Faculty Profiles". UCSF. Retrieved 18 March 2014.
  2. 1 2 3 Robinson, Mark. "Tilting at Tobacco". Stanford University. Retrieved 16 December 2014.
  3. "UCSF settles sexual harassment suit involving star researcher". STAT. 2018-10-16. Retrieved 2019-01-07.
  4. 1 2 S. Glantz, et al., "The Cigarette Papers", University of California Press, 1996
  5. S. Glantz, Primer of Biostatistics (6 ed), McGraw-Hill, 2005
  6. "Faculty". ucsf.edu. Archived from the original on 2014-02-21.
  7. 1 2 Asimov, Nanette (October 19, 2018). "UCSF agrees to $150K settlement over sexual harassment claim". San Francisco Chronicle.
  8. 1 2 Oransky, Ivan; Marcus, Adam (October 16, 2018). "UCSF settles sexual harassment suit involving star researcher". STAT.
  9. 1 2 Waxmann, Laura (March 28, 2018). "UCSF professor faces second sexual harassment lawsuit". San Francisco Examiner.
  10. 1 2 Howe, Rob (20 May 1996). "Battle of the Butts". People. Archived from the original on 27 April 2015. Retrieved 19 April 2015. ()
  11. 1 2 "Stanton A. Glantz, PhD". University of California. Retrieved 18 December 2014.
  12. "Our History". Stanford Engineering (Stanford University). Retrieved 18 December 2014.
  13. 1 2 3 4 "Stanton A. Glantz, PhD". University of California. Archived from the original on 16 December 2014. Retrieved 16 December 2014.
  14. "Stanton Glantz, PhD". University of California, San Francisco. Archived from the original on 4 December 2010. Retrieved 19 April 2015.
  15. Bach, John. "Anti-smoking crusader: Stanton Glantz, Eng '69". UC Magazine (University of Cincinnati). Retrieved 18 December 2014.
  16. Barnoya, J; Glantz, SA (24 May 2005). "Cardiovascular effects of secondhand smoke: nearly as large as smoking". Circulation. 111 (20): 2684–98. doi: 10.1161/CIRCULATIONAHA.104.492215 . PMID   15911719.
  17. Sargent, Richard P.; Shepard, R. M.; Glantz, S. A. (5 April 2004). "The Helena Study (Abstract)". BMJ. 328 (7446): 977–980. doi:10.1136/bmj.38055.715683.55. PMC   404491 . PMID   15066887 . Retrieved 2007-05-01.
  18. Alzahrani, T; Pena, I; Temesgen, N; Glantz, SA (Oct 2018). "Association Between Electronic Cigarette Use and Myocardial Infarction". American Journal of Preventive Medicine. 55 (4): 455–461. doi:10.1016/j.amepre.2018.05.004. PMC   6208321 . PMID   30166079.
  19. Glantz, SA; Barnes, DE; Bero, L; Hanauer, P; Slade, J (1995). "Looking through a keyhole at the tobacco industry. The Brown and Williamson documents". JAMA. 274 (3): 219–24. doi:10.1001/jama.1995.03530030039032. PMID   7609230.
  20. S. Glantz and E. Balbach. "Tobacco War: Inside the California Battles", University of California Press, 2000
  21. PBS Frontline, Interview with Stanton Glantz for Smoke in the Eye, 1999.
  22. "Study Confirms Tea Party Was Created by Big Tobacco and Billionaire Koch Brothers". The Huffington Post. 11 February 2013.
  23. JAMA Pediatrics, 6 March 2014, Electronic Cigarettes and Conventional Cigarette Use Among US Adolescents, retrieved 6 Mar 2014
  24. Sabrina Tavernise, "Young Using E-Cigarettes Smoke Too, Study Finds" New York Times March 6, 2014
  25. National Academies of Sciences, Engineering, and Medicine; Health And Medicine, Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems; Eaton, D. L.; Kwan, L. Y.; Stratton, K. (2018). Stratton, Kathleen; Kwan, Leslie Y.; Eaton, David L. (eds.). Public Health Consequences of E-Cigarettes : Health and Medicine Division. The National Academies Press. doi:10.17226/24952. ISBN   9780309468343. PMID   29894118.{{cite book}}: |website= ignored (help)CS1 maint: multiple names: authors list (link)
  26. Glantz, SA; Nguyen, N; Oliveira da Silva, AL (2024). Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes, NEJM Evidence, https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300229
  27. Glantz, Stanton A.; Nguyen, Nhung (27 February 2024). "Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes".
  28. Glantz, Stanton A.; Nguyen, Nhung; Oliveira Da Silva, A. L. (27 February 2024). "Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes". NEJM Evidence. 3 (3): EVIDoa2300229. doi:10.1056/EVIDoa2300229. PMID   38411454.
  29. "Tobacco Control Archives". University of California, San Francisco. Retrieved 6 March 2019.
  30. Hochschild, Adam (March 1996). "Shoot-Out in Marlboro Country (cont'd)". Mother Jones . Retrieved June 2, 2013.
  31. "'Death in the West' to be resurrected". The Herald (Glasgow) . May 11, 1982. p. 6. Retrieved June 2, 2014.
  32. "ree Curriculum Guide and Broadcast of 'death in the West' 000129 and 000131". Tobacco Documents Online. Archived from the original on 2014-12-16. Retrieved 16 December 2014.
  33. S. Glantz, Tobacco: Biology and Politics Archived 2007-03-01 at the Wayback Machine , WRS HealthEdCo
  34. Karen Butter; Robin Chandler & John Kunze (November 1996). "The Cigarette Papers: Issues in Publishing Materials in Multiple Formats". D-Lib Magazine.
  35. Wiener, Jon (1 January 1996). "The Cigarette Papers". PBS. Retrieved 17 December 2014. This is an authorized reprint of an article that appeared in The Nation in 1994.
  36. "Cigarette Wars". CNBC. 3 February 2012. Retrieved 8 March 2015.
  37. "Merchants of Doubt". Sony Pictures Classics. Retrieved 8 March 2015.
  38. PBS Frontline, Interview with Stanton Glantz for Inside the Tobacco Deal, 1997
  39. Brion J. Fox J.D., James M. Lightwood Ph.D., and Stanton A. Glantz Ph.D., "A Public Health Analysis of the Proposed Resolution of [the 1997 United States] Tobacco Litigation" (February 1, 1998). Center for Tobacco Control Research and Education. Tobacco Control Policy Making: United States. Paper US1998. http://repositories.cdlib.org/ctcre/tcpmus/US1998
  40. "A High-Profile Anti-Tobacco Crusader Is Being Sued For Sexual Harassment". Buzzfeed. December 7, 2017.
  41. "Former UCSF researcher sues UC regents, UCSF professor for alleged sex harassment". The Daily Californian. December 7, 2017.
  42. "UCSF professor, prominent tobacco control activist accused of sexual harassment by former mentee". San Francisco Examiner.
  43. O'Lonergan, Theresa. "UCSF letter to American Association for Cancer Research (PDF)" (PDF). Retrieved 2 January 2021.
  44. "Settlement Agreement and Release of All Claims (PDF)" (PDF). Retrieved 13 November 2020.